Gapping down
In reaction to earnings/guidance:
- BLI -31.4% (guides FY21 and FY22 revs below consensus, also CEO to step down), HUM -7.4% (to reaffirm 2021 guidance at upcoming conferences; initial 2022 Adjusted EPS guidance will include an explicit COVID related headwind), HEAR -4.2% (sees FY21 revs at low end of prior guidance), BBWI -2.5% (sees Q4 at high-end of guidance) SCHN -1.2%
Other news:
- STRO -15.3% (announces interim data from dose-expansion cohort of STRO-002 Phase 1 study)
- SGMO -9.8% (was notified that Sanofi (SNY) terminated licensing agreement)
- RIOT -2% (produced 425 Bitcoin in December, up 334% yr/yr)
- AFCG -1.3% (prices its underwritten public offering of 3,000,000 shares of its common stock at a public offering price of $20.50/share)
- CNM -1% (prices secondary public offering of 20 mln shares of its Class A common stock by certain selling stockholders at $26.00/share)
Analyst comments:
- ESTC -4.1% (downgraded to Hold from Buy at Jefferies)
- AKAM -3.2% (downgraded to Neutral from Overweight at Piper Sandler)
- ADT -2.5% (downgraded to Sector Perform from Outperform at RBC)
- DG -2.4% (downgraded to Equal Weight from Overweight at Wells Fargo)
- KNX -1.3% (downgraded to Underperform from Peer Perform at Wolfe Research)
- GILD -1.1% (downgraded to Equal-Weight from Overweight at Morgan Stanley)